Apeikon Therapeutics
PrivateLast Round
Seed
Mar 31, 2023
Total Funding Raised
$1.37M
Company Overview
Apeikon Therapeutics is a biotechnology company that develops image-guided, activatable nanoparticle technology for the targeted delivery of anti-cancer drugs to tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apeikon Therapeutics Comparables
Compare Apeikon Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Advanced Microbubbles, Inc. | 77% | |
| OxSonics Therapeutics | 77% | |
| Exact Therapeutics AS | 76% | |
Apeikon Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 31, 2023 | ||||
| Angel | Nov 30, 2022 | ||||
| Grant | Mar 1, 2022 |
Apeikon Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| SFC Capital | Seed |
Apeikon Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Apeikon Therapeutics's valuation, stock price, and market status.